Do human RNA helicases have a role in cancer?

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1704, Issue 1, 2004, Pages 37-46

  Abdelhaleem, Mohamed ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Cancer; DDX and DHX; RNA helicase; RNA metabolism; Splicing; Transcription; Translation

Indexed keywords

ISOENZYME; RNA; RNA HELICASE;

BIOCHEMISTRY; CANCER CLASSIFICATION; CANCER GROWTH; CHROMOSOME TRANSLOCATION; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; HUMAN; MOLECULAR INTERACTION; MOLECULE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; REGULATORY MECHANISM; REVIEW;

DEAD-BOX RNA HELICASES; HUMANS; MEMBRANE PROTEINS; NEOPLASM PROTEINS; NEOPLASMS; PROTO-ONCOGENE PROTEINS; RNA HELICASES; RNA NUCLEOTIDYLTRANSFERASES;

EID: 3042669445     PISSN: 0304419X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbcan.2004.05.001     Document Type: Review

References (146)

1. Lander E.S., Linton L.M., Birren B., et al. Initial sequencing and analysis of the human genome. Nature. 409:2001;860-921
2. Balvay L., Libri D., Fiszman M.Y. Pre-mRNA secondary structure and the regulation of splicing. BioEssays. 15:1993;165-169
3. van der Velden A.W., Thomas A.A. The role of the 5′ untranslated region of an mRNA in translation regulation during development. Int. J. Biochem. Cell Biol. 31:1999;87-106
4. Luking A., Stahl U., Schmidt U. The protein family of RNA helicases. Crit. Rev. Biochem. Mol. Biol. 33:1998;259-296
5. Schmid S.R., Linder P. D-E-A-D protein family of putative RNA helicases. Mol. Microbiol. 6:1992;283-291
6. Jankowsky E., Gross C.H., Shuman S., Pyle A.M. Active disruption of an RNAprotein interaction by a DExH/D RNA helicase. Science. 291:2001;121-125
7. Silverman, Edwalds-Gilbert G., Lin R.J. DExD/H-box proteins and their partners: helping RNA helicases unwind. Gene. 312:2003;1-16
8. Gorbalenya A.E., Koonin E.V., Donchenko A.P., Blinov V.M. Two related superfamilies of putative helicases involved in replication, recombination, repair and expression of DNA and RNA genomes. Nucleic Acids Res. 17:1989;4713-4730
9. Linder P., Lasko P.F., Ashburner M., Leroy P., Nielsen P.J., Nishi K., Schnier J., Slonimski P.P. Birth of the D-E-A-D box. Nature. 337:1989;121-122
10. de la Cruz J., Kressler D., Linder P. Unwinding RNA in Saccharomyces cerevisiae: DEAD-box proteins and related families. Trends Biochem. Sci. 24:1999;192-198
11. Tanner N.K., Linder P. From RNA helicases to RNPases. Mol. Cell. 8:2001;251-262
12. Tanner N.K., Cordin O., Banroques J., Doere M., Linder P. The Q motif: a newly identified motif in DEAD box helicases may regulate ATP binding and hydrolysis. Mol. Cell. 11:2003;127-138
13. Linder P., Gasteiger E., Bairoch A. A comprehensive web resource on RNA helicases from the baker's yeast Saccharomyces cerevisiae. Yeast. 16:2000;507-509
14. Jankowsky E., Jankowsky A. The DExH/D protein family database. Nucleic Acids Res. 28:2000;333-334
15. Linder P., Stutz F. mRNA export: travelling with DEAD box proteins. Curr. Biol. 11:2001;R961-R963
16. Linder P., Tanner N.K., Banroques J. From RNA helicases to RNPases. Trends Biochem. Sci. 26:2001;339-341
17. Boudet N., Aubourg S., Toffano-Nioche C., Kreis M., Lecharny A. Evolution of intron/exon structure of DEAD helicase family genes in Arabidopsis, Caenorhabditis, and Drosophila. Genome Res. 11:2001;2101-2114
18. Linder P. Yeast RNA helicases of the DEAD-box family involved in translation initiation. Biol. Cell. 95:2003;157-167
19. www.helicase.net.
20. Abdelhaleem M., Maltais L., Wain H. The human DDX and DHX gene families of putative RNA helicases. Genomics. 81:2003;618-622
21. Ji W., Chen F., Do T., Do A., Roe B.A., Meisler M.H. DQX1, an RNA-dependent ATPase homolog with a novel DEAQ box: expression pattern and genomic sequence comparison of the human and mouse genes. Meisler Mamm. Genome. 12:2001;456-461
22. Abdelhaleem M. The novel helicase homologue DDX32 is down-regulated in acute lymphoblastic leukemia. Leuk. Res. 26:2002;945-954
23. vanBrabant A.J., Stan R., Ellis N.A. DNA helicases, genomic instability, and human genetic disease. Annu. Rev. Genomics Hum. Genet. 1:2000;409-459
24. Hickson I.D. RecQ helicases: caretakers of the genome. Nat. Rev., Cancer. 3:2003;169-178
25. Godbout R., Squire J. Amplification of a DEAD box protein gene in retinoblastoma cell lines. Proc. Natl. Acad. Sci. U. S. A. 90:1993;7578-7582
26. Squire J.A., Thorner P.S., Weitzman S., Maggi J.D., Dirks P., Doyle J., Hale M., Godbout R. Co-amplification of MYCN and a DEAD box gene (DDX1) in primary neuroblastoma. Oncogene. 10:1995;1417-1422
27. Godbout R., Packer M., Bie W. Overexpression of a DEAD box protein (DDX1) in neuroblastoma and retinoblastoma cell lines. J. Biol. Chem. 273:1998;21161-21168
28. Karlsson A., Helou K., Walentinsson A., Hedrich H.J., Szpirer C., Levan G. Amplification of Mycn, Ddx1, Rrm2, and Odc1 in rat uterine endometrial carcinomas. Genes Chromosomes Cancer. 31:2001;345-356
29. Chen H.C., Lin W.C., Tsay Y.G., Lee S.C., Chang C.J. An RNA helicase, DDX1, interacting with poly(A) RNA and heterogeneous nuclear ribonucleoprotein K. J. Biol. Chem. 277:2002;40403-40409
30. Bleoo S., Sun X., Hendzel M.J., Rowe J.M., Packer M., Godbout R. Association of human DEAD box protein DDX1 with a cleavage stimulation factor involved in 3′-end processing of pre-MRNA. Mol. Biol. Cell. 12:2001;3046-3059
31. Godbout R., Packer M., Katyal S., Bleoo S. Cloning and expression analysis of the chicken DEAD box gene DDX1. Biochim. Biophys. Acta. 1574:2002;63-71
32. Manohar C.F., Salwen H.R., Brodeur G.M., Cohn S.L. Co-amplification and concomitant high levels of expression of a DEAD box gene with MYCN in human neuroblastoma. Genes Chromosomes Cancer. 14:1995;196-203
33. George R.E., Kenyon R.M., McGuckin A.G., Malcolm A.J., Pearson A.D., Lunec J. Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma, United Kingdom Children's Cancer Study Group. Oncogene. 12:1996;1583-1587
34. Noguchi T., Akiyama K., Yokoyama M., Kanda N., Matsunaga T., Nishi Y. Amplification of a DEAD box gene (DDX1) with the MYCN gene in neuroblastomas as a result of cosegregation of sequences flanking the MYCN locus. Genes Chromosomes Cancer. 15:1996;129-133
35. Kuroda H., White P.S., Sulman E.P., Manohar C.F., Reiter J.L., Cohn S.L., Brodeur G.M. Physical mapping of the DDX1 gene to 340 kb 5′ of MYCN. Oncogene. 13:1996;1561-1565
36. Amler L.C., Schurmann J., Schwab M. The DDX1 gene maps within 400 kbp 5′ to MYCN and is frequently coamplified in human neuroblastoma. Genes Chromosomes Cancer. 15:1996;134-137
37. George R.E., Kenyon R., McGuckin A.G., Kohl N., Kogner P., Christiansen H., Pearson A.D., Lunec J. Analysis of candidate gene co-amplification with MYCN in neuroblastoma. Eur. J. Cancer. 33:1997;2037-2042
38. Pandita A., Godbout R., Zielenska M., Thorner P., Bayani J., Squire J.A. Relational mapping of MYCN and DDXI in band 2p24 and analysis of amplicon arrays in double minute chromosomes and homogeneously staining regions by use of free chromatin FISH. Genes Chromosomes Cancer. 20:1997;243-252
39. De Preter K., Speleman F., Combaret V., Lunec J., Laureys G., Eussen B.H., Francotte N., Board J., Pearson A.D., De Paepe A., Van Roy N., Vandesompele J. Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay. Mod. Path. 15:2002;159-166
40. Scott D., Elsden J., Pearson A., Lunec J. Genes co-amplified with MYCN in neuroblastoma: silent passengers or co-determinants of phenotype? Cancer Lett. 197:2003;81-86
41. Rogers G.W. Jr., Komar A.A., Merrick W.C. eIF4A: the godfather of the DEAD box helicases. Prog. Nucleic Acid Res. Mol. Biol. 72:2002;307-331
42. Li Q., Imataka H., Morino S., Rogers G.W. Jr., Richter-Cook N.J., Merrick W.C., Sonenberg N. Eukaryotic translation initiation factor 4AIII (eIF4AIII) is functionally distinct from eIF4AI and eIF4AII. Mol. Cell. Biol. 19:1999;7336-7346
43. Rogers G.W., Richter N.J., Lima W.F., Merrick W.C. Modulation of the helicase activity of eIF4A by eIF4B, eIF4H, and eIF4F. J. Biol. Chem. 276:2001;30914-30922
44. Pause A., Sonenberg N. Mutational analysis of a DEAD box RNA helicase: the mammalian translation initiation factor eIF-4A. EMBO J. 11:1992;2643-2654
45. Pause A., Methot N., Sonenberg N. The HRIGRXXR region of the DEAD box RNA helicase eukaryotic translation initiation factor 4A is required for RNA binding and ATP hydrolysis. Mol. Cell. Biol. 13:1993;6789-6798
46. Caruthers J.M., Johnson E.R., McKay D.B. Crystal structure of yeast initiation factor 4A, a DEAD-box RNA helicase. Proc. Natl. Acad. Sci. U. S. A. 97:2000;13080-13085
47. Gingras C., Raught B., Sonenberg N. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu. Rev. Biochem. 68:1999;913-963
48. Svitkin Y.V., Pause A., Haghighat A., Pyronnet S., Witherell G., Belsham G.J., Sonenberg N. The requirement for eukaryotic initiation factor 4A (elF4A) in translation is in direct proportion to the degree of mRNA 5′ secondary structure. RNA. 7:2001;382-394
49. Eberle J., Krasagakis K., Orfanos C.E. Translation initiation factor eIF-4A1 mRNA is consistently overexpressed in human melanoma cells in vitro. Int. J. Cancer. 71:1997;396-401
50. Eberle J., Fecker L.F., Bittner J.U., Orfanos C.E., Geilen C.C. Decreased proliferation of human melanoma cell lines caused by antisense RNA against translation factor eIF-4A1. Br. J. Cancer. 86:2002;1957-1962
51. Shuda M., Kondoh N., Tanaka K., Ryo A., Wakatsuki T., Hada A., Goseki N., Igari T., Hatsuse K., Aihara T., Horiuchi S., Shichita M., Yamamoto N., Yamamoto M. Enhanced expression of translation factor mRNAs in hepatocellular carcinoma. Anticancer Res. 20:2000;2489-2494
52. Wang W.B., Boing S., Zhou X.Q., Ji P., Dong Y., Yao Q., Muller-Tidow C. Identification of metastasis-associated genes in early stage non-small cell lung cancer by subtractive hybridization. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 34:2002;273-278
53. Yang H.S., Jansen A.P., Nair R., Shibahara K., Verma A.K., Cmarik J.L., Colburn N.H. A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation. Oncogene. 20:2001;669-676
54. Yang H.S., Jansen A.P., Komar A.A., Zheng X., Merrick W.C., Costes S., Lockett S.J., Sonenberg N., Colburn N.H. The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol. Cell. Biol. 23:2003;26-37
55. Yang H.S., Knies J.L., Stark C., Colburn N.H. Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation. Oncogene. 22:2003;3712-3720
56. Lane D.P., Hoeffler W.K. SV40 large T shares an antigenic determinant with a cellular protein of molecular weight 68, 000. Nature. 288:1980;167-170
57. Ford M.J., Anton I.A., Lane D.P. Nuclear protein with sequence homology to translation initiation factor eIF-4A. Nature. 332:1988;736-738
58. Scheffner M., Knippers R., Stahl H. RNA unwinding activity of SV40 large T antigen. Cell. 57:1989;955-963
59. Hirling H., Scheffner M., Restle T., Stahl H. RNA helicase activity associated with the human p68 protein. Nature. 339:1989;562-564
60. Iggo R.D., Lane D.P. Nuclear protein p68 is an RNA-dependent ATPase. EMBO J. 8:1989;1827-1831
61. Iggo R.D., Jamieson D.J., MacNeill S.A., Southgate J., McPheat J., Lane D.P. p68 RNA helicase: identification of a nucleolar form and cloning of related genes containing a conserved intron in yeasts. Mol. Cell. Biol. 11:1991;1326-1333
62. Huang Y., Liu Z.R. The ATPase, RNA unwinding, and RNA binding activities of recombinant p68 RNA helicase. J. Biol. Chem. 277:2002;12810-12815
63. Buelt M.K., Glidden B.J., Storm D.R. Regulation of p68 RNA helicase by calmodulin and protein kinase. J. Biol. Chem. 269:1994;29367-29370
64. Lemaire L., Heinlein U.A. High-level expression in male germ cells of murine P68 RNA helicase mRNA. Life Sci. 52:1993;917-926
65. Sandhu H., Lemaire L., Heinlein U.A. Male germ cell extracts contain proteins binding to the conserved 3′-end of mouse p68 RNA helicase mRNA. Biochem. Biophys. Res. Commun. 214:1995;632-638
66. Gingras M.C., Margolin J.F. Differential expression of multiple unexpected genes during U937 cell andmacrophage differentiation detected by suppressive subtractive hybridization. Exp. Hematol. 28:2000;65-76
67. Stevenson R.J., Hamilton S.J., MacCallum D.E., Hall P.A., Fuller-Pace F.V. Expression of the 'dead box' RNA helicase p68 is developmentally and growth regulated and correlates with organ differentiation/maturation in the fetus. J. Pathol. 184:1998;351-359
68. Seufert W., Kos R., Erickson C.A., Swalla B.J. p68, a DEAD-box RNA helicase, is expressed in chordate embryo neural and mesodermal tissues. J. Exp. Zool. 288:2000;193-204
69. Kitamura A., Nishizuka M., Tominaga K., Tsuchiya T., Nishihara T., Imagawa M. Expression of p68 RNA helicase is closely related to the early stage of adipocyte differentiation of mouse 3T3-L1 cells. Biochem. Biophys. Res. Commun. 287:2001;435-439
70. Liu Z.R. p68 RNA helicase is an essential human splicing factor that acts at the U1 snRNA-5′ splice site duplex. Mol. Cell. Biol. 22:2002;5443-5450
71. Guil S., Gattoni R., Carrascal M., Abian J., Stevenin J., Bach-Elias M. Roles of hnRNP A1, SR proteins, and p68 helicase in c-H-ras alternative splicing regulation. Mol. Cell. Biol. 23:2003;2927-2941
72. Endoh H., Maruyama K., Masuhiro Y., Kobayashi Y., Goto M., Tai H., Yanagisawa J., Metzger D., Hashimoto S., Kato S. Purification and identification of p68 RNA helicase acting as a transcriptional coactivator specific for the activation function 1 of human estrogen receptor alpha. Mol. Cell. Biol. 19:1999;5363-5372
73. Rossow K.L., Janknecht R. Synergism between p68 RNA helicase and the transcriptional coactivators CBP and p300. Oncogene. 22:2003;151-156
74. Ogilvie V.C., Wilson B.J., Nicol S.M., Morrice N.A., Saunders L.R., Barber G.N., Fuller-Pace F.V. The highly related DEAD box RNA helicases p68 and p72 exist as heterodimers in cells. Nucleic Acids Res. 31:2003;1470-1480
75. Uhlmann-Schiffler H., Rossler O.G., Stahl H. The mRNA of DEAD box protein p72 is alternatively translated into an 82-kDa RNA helicase. J. Biol. Chem. 277:2002;1066-1075
76. Lamm G.M., Nicol S.M., Fuller-Pace F.V., Lamond A.I. p72: a human nuclear DEAD box protein highly related to p68. Nucleic Acids Res. 24:1996;3739-3747
77. Lee C.G. RH70, a bidirectional RNA helicase, co-purifies with U1snRNP. J. Biol. Chem. 277:2002;39679-39683
78. Rossler O.G., Hloch P., Schutz N., Weitzenegger T., Stahl H. Structure and expression of the human p68 RNA helicase gene. Nucleic Acids Res. 28:2000;932-939
79. Honig A., Auboeuf D., Parker M.M., O'Malley B.W., Berget S.M. Regulation of alternative splicing by the ATP-dependent DEAD-box RNA helicase p72. Mol. Cell. Biol. 22:2002;5698-5707
80. Jothy S. CD44 and its partners in metastasis. Clin. Exp. Metastasis. 20:2003;195-201
81. Dubey P., Hendrickson R.C., Meredith S.C., Siegel C.T., Shabanowitz J., Skipper J.C., Engelhard V.H., Hunt D.F., Schreiber H. The immunodominant antigen of an ultraviolet-induced regressor tumor is generated by a somatic point mutation in the DEAD box helicase p68. J. Exp. Med. 185:1997;695-705
82. Causevic M., Hislop R.G., Kernohan N.M., Carey F.A., Kay R.A., Steele R.J., Fuller-Pace F.V. Overexpression and poly-ubiquitylation of the DEAD-box RNA helicase p68 in colorectal tumours. Oncogene. 20:2001;7734-7743
83. Akao Y., Tsujimoto Y., Finan J., Nowell P.C., Croce C.M. Molecular characterization of a t(11;14)(q23;q32) chromosome translocation in a B-cell lymphoma. Cancer Res. 50:1990;4856-4859
84. Akao Y., Seto M., Takahashi T., Saito M., Utsumi K.R., Nakazawa S., Ueda R. Rearrangements on chromosome 11q23 in hematopoietic tumor-associated t(11;14) and t(11;19) translocations. Cancer Res. 51:1991;6708-6711
85. Akao Y., Seto M., Takahashi T., Kubonishi I., Miyoshi I., Nakazawa S., Tsujimoto Y., Croce C.M., Ueda R. Molecular cloning of the chromosomal breakpoint of a B-cell lymphoma with the t(11;14)(q23;q32) translocation. Cancer Res. 51:1991;1574-1576
86. Akao Y., Seto M., Yamamoto K., Iida S., Nakazawa S., Inazawa J., Abe T., Takahashi T., Ueda R. The RCK gene associated with t(11;14) translocation is distinct from the MLL/ALL-1 gene with t(4;11) and t(11;19) translocations. Cancer Res. 52:1992;6083-6087
87. Lu D., Yunis J.J. Cloning, expression and localization of an RNA helicase gene from a human lymphoid cell line with chromosomal breakpoint 11q23.3. Nucleic Acids Res. 20:1992;1967-1972
88. Akao Y., Marukawa O., Morikawa H., Nakao K., Kamei M., Hachiya T., Tsujimoto Y. The rck/p54 candidate proto-oncogene product is a 54-kilodalton D-E-A-D box protein differentially expressed in human and mouse tissues. Cancer Res. 55:1995;3444-3449
89. Miyaji K., Nakagawa Y., Matsumoto K., Yoshida H., Morikawa H., Hongou Y., Arisaka Y., Kojima H., Inoue T., Hirata I., Katsu K., Akao Y. Overexpression of a DEAD box/RNA helicase protein, rck/p54, in human hepatocytes from patients with hepatitis C virus-related chronic hepatitis and its implication in hepatocellular carcinogenesis. J. Viral Hepatitis. 10:2003;241-248
90. Nakagawa Y., Morikawa H., Hirata I., Shiozaki M., Matsumoto A., Maemura K., Nishikawa T., Niki M., Tanigawa N., Ikegami M., Katsu K., Akao Y. Overexpression of rck/p54, a DEAD box protein, in human colorectal tumours. Br. J. Cancer. 80:1999;914-917
91. Hashimoto K., Nakagawa Y., Morikawa H., Niki M., Egashira Y., Hirata I., Katsu K., Akao Y. Co-overexpression of DEAD box protein rck/p54 and c-myc protein in human colorectal adenomas and the relevance of their expression in cultured cell lines. Carcinogenesis. 22:2001;1965-1970
92. Akao Y., Yoshida H., Matsumoto K., Matsui T., Hogetu K., Tanaka N., Usukura J. A tumour-associated DEAD-box protein, rck/p54 exhibits RNA unwinding activity toward c-myc RNAs in vitro. Genes Cells. 8:2003;671-676
93. Lee C.G., Hurwitz J. Human RNA helicase A is homologous to the maleless protein of Drosophila. J. Biol. Chem. 268:1993;16822-16830
94. Zhang S., Maacke H., Grosse F. Molecular cloning of the gene encoding nuclear DNA helicase II. A bovine homologue of human RNA helicase A and Drosophila Mle protein. J. Biol. Chem. 270:1995;16422-16427
95. Meller V.H. Initiation of dosage compensation in Drosophila embryos depends on expression of the roX RNAs. Mech. Dev. 120:2003;759-767
96. Richter L., Bone J.R., Kuroda M.I. RNA-dependent association of the Drosophila maleless protein with the male X chromosome. Genes Cells. 1:1996;325-336
97. Zhang S., Grosse F. Domain structure of human nuclear DNA helicase II (RNA helicase A). J. Biol. Chem. 272:1997;11487-11494
98. Lee C.G., Chang K.A., Kuroda M.I., Hurwitz J. The NTPase/helicase activities of Drosophila maleless, an essential factor in dosage compensation. EMBO J. 16:1997;2671-2681
99. Lee C.G., Costa Soares da V., Newberger C., Manova K., Lacy E., Hurwitz J. RNA helicase A is essential for normal gastrulation. Proc. Natl. Acad. Sci. U. S. A. 95:1998;13709-13713
100. Zhang S., Schlott B., Gorlach M., Grosse F. DNA-dependent protein kinase (DNA-PK) phosphorylates nuclear DNA helicase II/RNA helicase A and hnRNP proteins in an RNA-dependent manner. Nucleic Acids Res. 32:2004;1-10
101. Takeda Y., Caudell P., Grady G., Wang G., Suwa A., Sharp G.C., Dynan W.S., Hardin J.A. Human RNA helicase A is a lupus autoantigen that is cleaved during apoptosis. J. Immunol. 163:1999;6269-6274
102. Abdelhaleem M. The actinomycin D-induced apoptosis in BCR-ABL-positive K562 cells is associated with cytoplasmic translocation and cleavage of RNA helicase A. Anticancer Res. 23:2003;485-490
103. Gibson T.J., Thompson J.D. Detection of dsRNA-binding domains in RNA helicase A and Drosophila maleless: implications for monomeric RNA helicases. Nucleic Acids Res. 22:1994;2552-2556
104. Hung M.L., Chao P., Chang K.Y. dsRBM1 and a proline-rich domain of RNA helicase A can form a composite binder to recognize a specific dsDNA. Nucleic Acids Res. 31:2003;5741-5753
105. Nakajima T., Uchida C., Anderson S.F., Lee C.G., Hurwitz J., Parvin J.D., Montminy M. RNA helicase A mediates association of CBP with RNA polymerase II. Cell. 90:1997;1107-1112
106. Aratani S., Fujii R., Oishi T., Fujita H., Amano T., Ohshima T., Hagiwara M., Fukamizu A., Nakajima T. Dual roles of RNA helicase A in CREB-dependent transcription. Mol. Cell. Biol. 21:2001;4460-4469
107. Aratani S., Fujii R., Fujita H., Fukamizu A., Nakajima T. Aromatic residues are required for RNA helicase A mediated transactivation. Int. J. Mol. Med. 12:2003;175-180
108. Anderson S.F., Schlegel B.P., Nakajima T., Wolpin E.S., Parvin J.D. BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A. Nat. Genet. 19:1998;254-256
109. Schlegel P., Starita L.M., Parvin J.D. Overexpression of a protein fragment of RNA helicase A causes inhibition of endogenous BRCA1 function and defects in ploidy and cytokinesis in mammary epithelial cells. Oncogene. 22:2003;983-991
110. Zhou K., Choe K.T., Zaidi Z., Wang Q., Mathews M.B., Lee C.G. RNA helicase A interacts with dsDNA and topoisomerase IIalpha. Nucleic Acids Res. 31:2003;2253-2260
111. Fuchsova B., Novak P., Kafkova J., Hozak P. Nuclear DNA helicase II is recruited to IFN-alpha-activated transcription sites at PML nuclear bodies. J. Cell Biol. 158:2002;463-473
112. Myohanen S., Baylin S.B. Sequence-specific DNA binding activity of RNA helicase A to the p16INK4a promoter. J. Biol. Chem. 276:2001;1634-1642
113. Zhang S., Herrmann C., Grosse F. Pre-mRNA and mRNA binding of human nuclear DNA helicase II (RNA helicase A). J. Cell Sci. 112(Pt 7):1999;1055-1064
114. Tang H., Gaietta G.M., Fischer W.H., Ellisman M.H., Wong-Staal F. A cellular cofactor for the constitutive transport element of type D retrovirus. Science. 276:1997;1412-1415
115. Li J., Tang H., Mullen T.M., Westberg C., Reddy T.R., Rose D.W., Wong-Staal F. A role for RNA helicase A in post-transcriptional regulation of HIV type 1. Proc. Natl. Acad. Sci. U. S. A. 96:1999;709-714
116. Reddy T.R., Tang H., Xu W., Wong-Staal F. Sam68, RNA helicase A and Tap cooperate in the post-transcriptional regulation of human immunodeficiency virus and type D retroviral mRNA. Oncogene. 19:2000;3570-3575
117. Tang H., Wong-Staal F. Specific interaction between RNA helicase A and Tap, two cellular proteins that bind to the constitutive transport element of type D retrovirus. J. Biol. Chem. 275:2000;32694-32700
118. Tang H., McDonald D., Middlesworth T., Hope T.J., Wong-Staal F. The carboxyl terminus of RNA helicase A contains a bidirectional nuclear transport domain. Mol. Cell. Biol. 19:1999;3540-3550
119. Fujii R., Okamoto M., Aratani S., Oishi T., Ohshima T., Taira K., Baba M., Fukamizu A., Nakajima T. A role of RNA helicase A in cis-acting transactivation response element-mediated transcriptional regulation of human immunodeficiency virus type 1. J. Biol. Chem. 276:2001;5445-5451
120. Wei X., Pacyna-Gengelbach M., Schluns K., An Q., Gao Y., Cheng S., Petersen I. Analysis of the RNA helicase A gene in human lung cancer. Oncol. Rep. 11:2004;253-258
121. Savitsky K., Ziv Y., Bar-Shira A., Gilad S., Tagle D.A., Smith S., Uziel T., Sfez S., Nahmias J., Sartiel A., Eddy R.L., Shows T.B., Collins F.S., Shiloh Y., Rotman G. A human gene (DDX10) encoding a putative DEAD-box RNA helicase at 11q22-q23. Genomics. 33:1996;199-206
122. Arai Y., Hosoda F., Kobayashi H., Arai K., Hayashi Y., Kamada N., Kaneko Y., Ohki M. The inv(11)(p15q22) chromosome translocation of de novo and therapy-related myeloid malignancies results in fusion of the nucleoporin gene, NUP98, with the putative RNA helicase gene DDX10. Blood. 89:1997;3936-3944
123. Ikeda T., Ikeda K., Sasaki K., Kawakami K., Takahara J. The inv(11)(p15q22) chromosome translocation of therapy-related myelodysplasia with NUP98-DDX10 and DDX10-NUP98 fusion transcripts. Int. J. Hematol. 69:1999;160-164
124. Nakao K., Nishino M., Takeuchi K., Iwata M., Kawano A., Arai Y., Ohki M. Fusion of the nucleoporin gene, NUP98, and the putative RNA helicase gene, DDX10, by inversion 11 (p15q22) chromosome translocation in a patient with etoposide-related myelodysplastic syndrome. Intern. Med. 39:2000;412-415
125. Griffis E.R., Xu S., Powers M.A. Nup98 localizes to both nuclear and cytoplasmic sides of the nuclear pore and binds to two distinct nucleoporin subcomplexes. Mol. Biol. Cell. 14:2003;600-610
126. Martin A., Schneider S., Schwer B. Prp43 is an essential RNA-dependent ATPase required for release of lariat-intron from the spliceosome. J. Biol. Chem. 277:2002;17743-17750
127. Meng X., Liu J., Shen Z. Genomic structure of the human BCCIP gene and its expression in cancer. Gene. 302:2003;139-146
128. Liu J., Yuan Y., Huan J., Shen Z. Inhibition of breast and brain cancer cell growth by BCCIPalpha, an evolutionarily conserved nuclear protein that interacts with BRCA2. Oncogene. 20:2001;336-345
129. Martelange V., De Smet C., De Plaen E., Lurquin C., Boon T. Identification on a human sarcoma of two new genes with tumor-specific expression. Cancer Res. 60:2000;3848-3855
130. Doorbar J., Elston R.C., Napthine S., Raj K., Medcalf E., Jackson D., Coleman N., Griffin H.M., Masterson P., Stacey S., Mengistu Y., Dunlop J. The E1E4 protein of human papillomavirus type 16 associates with a putative RNA helicase through sequences in its C terminus. J. Virol. 74:2000;10081-10095
131. Holzmann K., Gerner C., Poltl A., Schafer R., Obrist P., Ensinger C., Grimm R., Sauermann G. A human common nuclear matrix protein homologous to eukaryotic translation initiation factor 4A. Biochem. Biophys. Res. Commun. 267:2000;339-344
132. Lee S., Baek M., Yang H., Bang Y.J., Kim W.H., Ha J.H., Kim D.K., Jeoung D.I. Identification of genes differentially expressed between gastric cancers and normal gastric mucosa with cDNA microarrays. Cancer Lett. 184:2002;197-206
133. Cho B., Lim Y., Lee D.Y., Park S.Y., Lee H., Kim W.H., Yang H., Bang Y.J., Jeoung D.I. Identification and characterization of a novel cancer/testis antigen gene CAGE. Biochem. Biophys. Res. Commun. 292:2002;715-726
134. Cho B., Lee H., Jeong S., Bang Y.J., Lee H.J., Hwang K.S., Kim H.Y., Lee Y.S., Kang G.H., Jeoung D.I. Promoter hypomethylation of a novel cancer/testis antigen gene CAGE is correlated with its aberrant expression and is seen in premalignant stage of gastric carcinoma. Biochem. Biophys. Res. Commun. 307:2003;52-63
135. Xu Q., Lee C. Discovery of novel splice forms and functional analysis of cancer-specific alternative splicing in human expressed sequences. Nucleic Acids Res. 31:2003;5635-5643
136. Jiang Z.H., Wu J.Y. Alternative splicing and programmed cell death. Proc. Soc. Exp. Biol. Med. 220:1999;64-72
137. Stickeler E., Kittrell F., Medina D., Berget S.M. Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis. Oncogene. 18:1999;3574-3582
138. Clemens M.J., Bommer U.A. Translational control: the cancer connection. Int. J. Biochem. Cell Biol. 31:1999;1-23
139. De Benedetti, Harris A.L. eIF4E expression in tumors: its possible role in progression of malignancies. Int. J. Biochem. Cell Biol. 31:1999;59-72
140. Dua K., Williams T.M., Beretta L. Translational control of the proteome: relevance to cancer. Proteomics. 1:2001;1191-1199
141. Watkins S.J., Norbury C.J. Translation initiation and its deregulation during tumorigenesis. Br. J. Cancer. 86:2002;1023-1027
142. Meric F., Hunt K.K. Translation initiation in cancer: a novel target for therapy. Mol. Cancer Ther. 1:2002;971-979
143. Calkhoven C.F., Muller C., Leutz A. Translational control of gene expression and disease. Trends Mol. Med. 8:2002;577-583
144. Ruggero D., Pandolfi P.P. Does the ribosome translate cancer? Nat. Rev., Cancer. 3:2003;179-192
145. Graff J.R., Zimmer S.G. Translational control and metastatic progression: enhanced activity of the mRNA cap-binding protein eIF-4E selectively enhances translation of metastasis-related mRNAs. Clin. Exp. Metastasis. 20:2003;265-273
146. Stoneley M., Willis A.E. Aberrant regulation of translation initiation in tumorigenesis. Curr. Mol. Med. 3:2003;597-603